Agency for Healthcare Research and Quality Notice of Meeting, 25767 [07-2238]
Download as PDF
<![CDATA[
pwalker on PROD1PC71 with NOTICES
Federal Register / Vol. 72, No. 87 / Monday, May 7, 2007 / Notices
Council, we are seeking individuals
who are distinguished: (1) In the
conduct of research, demonstration
projects, and evaluations with respect to
health care; (2) in the fields of health
care quality research or health care
improvement; (3) in the practice of
medicine; (4) in other health
professions; (5) in representing the
private health care sector (including
health plans, providers, purchasers) or
administrators of health care delivery
systems; (6) in the fields of health care
economics, information systems, law,
ethics, business, or public policy; and,
(7) in representing the interests of
patients and consumers of health care.
Individuals are particularly sought with
experience and success in activities
specified in the summary above.
DATES: Nominations should be received
on or before June 15, 2007.
ADDRESSES: Nominations should be sent
to Ms. Deborah Queenan, AHRQ, 540
Gaither Road, Room 3238, Rockville,
Maryland 20850. Nominations also may
be faxed to (301) 427–1341.
FOR FURTHER INFORMATION CONTACT: Ms.
Deborah Queenan, AHRQ, at (301) 427–
1330.
SUPPLEMENTARY INFORMATION: 42 U.S.C.
299c, section 931, of the PHS Act,
provides that the National Advisory
Council for Healthcare Research and
Quality shall consist of 21 appropriately
qualified representatives of the public
appointed by the Secretary of Health
and Human Services and, in addition,
ex officio representatives from other
Federal agencies specified in the
authorizing legislation, principally
agencies that conduct or support health
care research, as well as Federal officials
the Secretary may consider appropriate.
The Council meets in the Washington,
DC., metropolitan area, generally in
Rockville, Maryland, approximately
three times a year to provide broad
guidance to the Secretary and AHRQ’s
Director on the direction of and
programs undertaken by AHRQ.
Seven individuals will be selected
presently by the Secretary to serve on
the Council beginning with the meeting
in the spring of 2008. Members
generally serve 3-year terms.
Appointments are staggered to permit
an orderly rotation of membership.
Interested persons may nominate one
or more qualified persons for
membership on the Council. Selfnominations are accepted. Nominations
shall include: (1) A copy of the
nominee’s resume or curriculum vitae;
and (2) a statement that the nominee is
willing to serve as a member of the
Council. Selected candidates will be
asked to provide detailed information
VerDate Aug<31>2005
18:36 May 04, 2007
Jkt 211001
concerning their financial interests,
consultant positions and research grants
and contracts, to permit evaluation of
possible sources of conflict of interest.
The Department seeks a broad
geographic representation and has
special interest in assuring that women,
minority groups, and the physically
handicapped are adequately represented
on advisory bodies, and therefore,
particularly encourages nominations for
appropriately qualified female,
minority, and/or physically
handicapped candidates.
Dated: April 26, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07–2239 Filed 5–4–07; 8:45 am]
25767
Place: John M. Eisenberg Building, AHRQ
Conference Center, 540 Gaither Road,
Rockville, Maryland 20850.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priorities dictate.
Dated: April 23, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07–2238 Filed 5–2–07; 8:45 am]
BILLING CODE 4160–90–M
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is group of
experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for ‘‘Ambulatory Care
Patient Safety Proactive Risk
Assessment (P20),’’ are to be reviewed
and discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
information is exempt from mandatory
disclosure under the above-cited
statutes.
SEP Meeting on: Ambulatory Care Patient
Safety Proactive Risk Assessment (P20).
Date: May 21–22, 2007 (Open on May 21
from 8 a.m. to 8:15 a.m. and closed for the
remainder of the meeting).
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Pediatric Oncology Subcommittee of
the Oncologic Drugs Advisory
Committee; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting is open to the
public.
Name of Committee: Pediatric
Oncology Subcommittee of the
Oncologic Drugs Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on June 27, 2007, from 8 a.m. to 4
p.m.
Location: Food and Drug
Administration, Center for Drug
Evaluation and Research Advisory
Committee Conference Room, rm. 1066,
5630 Fishers Lane, Rockville, MD.
Contact Person: Mimi Phan, Center
for Drug Evaluation and Research (HFD–
21), Food and Drug Administration,
5600 Fishers Lane, (for express delivery,
5630 Fishers Lane, rm. 1093), Rockville,
MD 20857, 301–827–7001, FAX: 301–
827–6776, e-mail:
Mimi.Phan@fda.hhs.gov, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area), code
3014512542. Please call the Information
Line for up-to-date information on this
meeting.
Agenda: The subcommittee will do
the following: (1) Discuss review of
E:\FR\FM\07MYN1.SGM
07MYN1
]]>Agencies
[Federal Register Volume 72, Number 87 (Monday, May 7, 2007)]
[Notices]
[Page 25767]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-2238]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality Notice of Meeting
In accordance with section 10(d) of the Federal Advisory Committee
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care
Policy and Research Special Emphasis Panel (SEP) meeting.
A Special Emphasis Panel is group of experts in fields related to
health care research who are invited by the Agency for Healthcare
Research and Quality (AHRQ), and agree to be available, to conduct on
an as needed basis, scientific reviews of applications for AHRQ
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of
time. Rather, they are asked to participate in particular review
meetings which require their type of expertise.
Substantial segments of the upcoming SEP meeting listed below will
be closed to the public in accordance with the Federal Advisory
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C.
552b(c)(6). Grant applications for ``Ambulatory Care Patient Safety
Proactive Risk Assessment (P20),'' are to be reviewed and discussed at
this meeting. These discussions are likely to reveal personal
information concerning individuals associated with the applications.
This information is exempt from mandatory disclosure under the above-
cited statutes.
SEP Meeting on: Ambulatory Care Patient Safety Proactive Risk
Assessment (P20).
Date: May 21-22, 2007 (Open on May 21 from 8 a.m. to 8:15 a.m.
and closed for the remainder of the meeting).
Place: John M. Eisenberg Building, AHRQ Conference Center, 540
Gaither Road, Rockville, Maryland 20850.
Contact Person: Anyone wishing to obtain a roster of members,
agenda or minutes of the non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell, Committee Management Officer,
Office of Extramural Research, Education and Priority Populations,
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850,
Telephone (301) 427-1554.
Agenda items for this meeting are subject to change as
priorities dictate.
Dated: April 23, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07-2238 Filed 5-2-07; 8:45 am]
BILLING CODE 4160-90-M
